Brief, factual summary in English : A study in JAMA examined the effectiveness of nirsevimab in reducing respiratory syncytial virus (RSV)-related hospitalizations in newborns. Other research has focused on a mobile health app to support smoking cessation in people with tuberculosis. The studies provide important medical information and discussions that are shaping the future of medical practice and public health. In addition, JAMA magazine features other interesting topics, such as mitigating the risk of teen suicide with artificial intelligence chatbots. JAMA serves as a unique forum for the exchange of medical knowledge and discussions that influence the evolution of medicine and public health.